Xebio Holdings Co., Ltd. (8281.T) JPX

Currency In JPY

AD

Valuation

Market Cap41.07B
Enterprise Value31.55B
P/E Ratio120.54
PEG Ratio-0.69
Price/Sales Ratio0.17
Price/Book Ratio0.37
Enterprise/Revenue0.13
Enterprise/EBITDA3.09

Fiscal Year

Fiscal YearMarch 31, 2026
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0
Operating Margin0.01
AD

Management Effectiveness

Return On Assets0
Return On Equity0

Income Statement

Revenue252.33B
Revenue/Share6,192.68
Gross Profit95.09B
EBITDA4.76B
Net Income-2.16B
Diluted EPS-52.27

Balance Sheet

Total Cash22.4B
Total Cash/Share541.35
Total Debt12.15B
Total Debt/Equity0.1
Current Ratio1.8
Book Value Per Share2,897.09

Price History

52-Week Change-4.02
52-Week High1,251
52-Week Low951
Moving Average 50 Days1,136.82
Moving Average 200 Days1,073.64

Statistics

Average Volume135,651
Shares Outstanding41.38M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate35
Trailing Annual Dividend Yield3.26
Payout Ratio0
Last Split Factor3:2
Last Split DateMarch 28, 2006
AD